Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includesimmunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

$13.3B

Market Cap • 11/18/2024

1947

(77 years)
Founded

1983

(41 years ago)
IPO

NYSE

Listing Exchange
Flag of US

Waltham

Headquarters • Massachusetts

S&P500 Participant

Index Composite • 2024